New Approaches to Combat Antibiotic-Resistant Bacteria – 3rd Edition
Ascona, Switzerland
27 June – 1 July 2027
Over the past decades, pan-resistant strains of major bacterial pathogens have emerged, rendering available antibiotics ineffective and putting at risk many achievements of modern medicine. New ways to identify clinically effective antimicrobials are urgently needed.
However, the current antimicrobial development pipeline is inadequate because of high attrition and limited coverage of multi-drug-resistant Gram-negative bacteria. Revitalising antibiotic discovery requires a multidisciplinary approach starting at the bedside.
Many factors affect the development of novel antibiotics such as our limited understanding of the physiology and heterogeneity of bacterial pathogens in patients and their interactions with microbiota. Bacteria growing in patients experience environments that are very different from standard laboratory conditions traditionally used for antibacterial discovery.
NACARB will review the current knowledge of:
- Clinical relevance of antibiotic resilience
- Axenic model systems and single cell technologies
- Complex tissue model systems
- Drug penetrance and action through scale
- New approaches in antibiotic discovery and development
- Non-traditional antibacterials
The conference will introduce students to emerging concepts that promise to accelerate antibacterial discovery, improve treatment regimens, and uncover novel targets for eradicating pathogens. It will bring together world-leading clinicians, microbiologists, tissue engineers, and chemists who share common interests in the field and work towards the development of urgently needed control strategies to win the race against superbugs.
Terms and conditions coming soon